4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > Sino Biological/FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag)/1/10445-H08H
商品详细Sino Biological/FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag)/1/10445-H08H
Sino Biological/FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag)/1/10445-H08H
Sino Biological/FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag)/1/10445-H08H
商品编号: 10445-H08H
品牌: sinobiological
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag): Product Information

Purity
> 95 % as determined by SDS-PAGE
Endotoxin
< 1.0="" eu="" per="" μg="" of="" the="" protein="" as="" determined="" by="" the="" lal="">
Activity
Measured by its ability to bind biotinylated human FLT3L-His (Cat:10315-H07B) in a functional ELISA.
Protein Construction
A DNA sequence encoding the extracellular domain of human FLT3 (P36888-1, with natural variant Thr 227 Met) (Met1-Asn541) was expressed with a C-terminal polyhistidine tag.
Accession#
P36888-1
Expressed Host
HEK293 Cells
Species
Human
Predicted N Terminal
Asn 27
Molecule Mass
The recombinant human FLT3 consists of 526 amino acids and has a predicted molecular mass of 59.7 kDa. In SDS-PAGE under reducing conditions, it migrates with an apparent molecular mass of 85-95 kDa due to glycosylation.
Formulation
Lyophilized from sterile PBS, pH 7.4Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag): Images

Human FLT3/CD135/FLK-2 Protein 8818
Human FLT3 Protein 27966
Measured by its ability to bind biotinylated human FLT3L-His (Cat: 10315-H07B) in a functional ELISA.

FLT3 Protein, Human, Recombinant (T227M, ECD, His Tag): Synonyms

CD135 Protein, Human; FLK-2 Protein, Human; FLK2 Protein, Human; STK1 Protein, Human

FLT3 Background Information

The cluster of differentiation (CD) system is commonly used as cell markers in Immunophenotyping. Different kinds of cells in the immune system can be identified through the surface CD molecules which associating with the immune function of the cell. There are more than 320 CD unique clusters and subclusters have been identified. Some of the CD molecules serve as receptors or ligands important to the cell through initiating a signal cascade which then alter the behavior of the cell. Some CD proteins do not take part in cell signal process but have other functions such as cell adhesion. CD135, also known as FLT-3, FLK-2, is a member of the CD system. CD135 is an important cell surface marker recognized by specific sets of antibodies to identify the types of hematopoietic (blood) progenitors in the bone marrow and it function to differentiate hematopoietic stem cells, which are CD135 negative, from multipotent progenitors, which are CD135 positive. CD135 is a receptor tyrosine kinase typeⅢ for the cytokine Flt3 ligand and activat signaling through second messengers by binding to Flt3. Signaling through CD135 is important for lymphocyte development. The encoding gene CD135 is a proto-oncogene to which mutations happened will lead to cancer such as leukemia.
  • Cancer Immunotherapy
  • Immune Checkpoint
  • Immunotherapy
  • Targeted Therapy
Full Name
fms-related tyrosine kinase 3
Research Areas
  • Cancer Drug Targets
  • Receptor Tyrosine Kinases (RTKs)
References
  • Zola H, et al. (2007) CD molecules 2006-human cell differentiation molecules. J Immunol Methods. 318 (1-2): 1-5.
  • Ho IC, et al. (2009) GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 9 (2): 125-35.
  • Matesanz-Isabel J, et al. (2011) New B-cell CD molecules. Immunology Letters.134 (2): 104-12.
  • Bertho, et al. (2000) CD135 (Flk2 / Flt3) Expression by Human Thymocytes Delineates a Possible Role of FLT3-Ligand in T-Cell Precursor Proliferation and Differentiation. Scandinavian Journal of Immunology. 52 (1): 53-61.

Human FLT3 Proteins

  • FLT3 Protein, Human, Recombinant (ECD, hFc Tag)10445-H02H1

Mouse FLT3 Proteins

  • FLT3 Protein, Mouse, Recombinant (His Tag)51119-M08H
  • The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
    Author
    Steiner, N;Jöhrer, K;Plewan, S;Brunner-Véber, A;Göbel, G;Nachbaur, D;Wolf, D;Gunsilius, E;Untergasser, G;
    Year
    2020
    Journal
    Cancers (Basel)
    Application
    blocking
    PubMed ID: 32825035FoldedExpand

If you couldn"t find the specific citation, you can:

  • Find All Citations
  • Submit a CitationGet a Publication Reward
  • Leave Us a Message

E.coli protein expression service

Mammalian transient protein expression service

Baculovirus-insect expression service

Stable cell line development service (CHO / HEK293)

品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。